vs
Side-by-side financial comparison of NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $23.3M, roughly 1.7× NORTHERN TECHNOLOGIES INTERNATIONAL CORP). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 1.0%, a 34.9% gap on every dollar of revenue. On growth, NORTHERN TECHNOLOGIES INTERNATIONAL CORP posted the faster year-over-year revenue change (9.2% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-479.7K). Over the past eight quarters, NORTHERN TECHNOLOGIES INTERNATIONAL CORP's revenue compounded faster (5.8% CAGR vs -15.0%).
Maxar Technologies Inc., was an American space technology company, specializing in geospatial intelligence, Earth observation, and on-orbit satellite servicing, satellite products, and related services. DigitalGlobe and MDA Holdings Company merged to become Maxar Technologies on October 5, 2017.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
NTIC vs SBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.3M | $39.6M |
| Net Profit | $237.8K | $14.2M |
| Gross Margin | 36.0% | 73.1% |
| Operating Margin | 4.0% | 32.5% |
| Net Margin | 1.0% | 35.9% |
| Revenue YoY | 9.2% | -10.9% |
| Net Profit YoY | -57.6% | 117.2% |
| EPS (diluted) | $0.03 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.3M | $39.6M | ||
| Q3 25 | $22.3M | $43.4M | ||
| Q2 25 | $21.5M | $43.4M | ||
| Q1 25 | $19.1M | $47.3M | ||
| Q4 24 | $21.3M | $44.4M | ||
| Q3 24 | $23.3M | $53.1M | ||
| Q2 24 | $20.7M | $53.1M | ||
| Q1 24 | $20.8M | $54.8M |
| Q4 25 | $237.8K | $14.2M | ||
| Q3 25 | $-1.1M | $12.8M | ||
| Q2 25 | $121.8K | $2.5M | ||
| Q1 25 | $434.3K | $21.5M | ||
| Q4 24 | $561.1K | $6.5M | ||
| Q3 24 | $1.8M | $2.8M | ||
| Q2 24 | $976.6K | $18.5M | ||
| Q1 24 | $1.7M | $18.8M |
| Q4 25 | 36.0% | 73.1% | ||
| Q3 25 | 37.9% | 70.6% | ||
| Q2 25 | 38.4% | 69.2% | ||
| Q1 25 | 35.6% | 79.7% | ||
| Q4 24 | 38.3% | 76.3% | ||
| Q3 24 | 43.8% | 81.5% | ||
| Q2 24 | 38.2% | 74.2% | ||
| Q1 24 | 40.0% | 72.1% |
| Q4 25 | 4.0% | 32.5% | ||
| Q3 25 | 4.2% | 36.6% | ||
| Q2 25 | 4.0% | 33.6% | ||
| Q1 25 | -1.7% | 51.1% | ||
| Q4 24 | 5.2% | 10.6% | ||
| Q3 24 | 11.8% | 26.1% | ||
| Q2 24 | 7.4% | 51.4% | ||
| Q1 24 | 10.6% | 44.6% |
| Q4 25 | 1.0% | 35.9% | ||
| Q3 25 | -4.9% | 29.6% | ||
| Q2 25 | 0.6% | 5.7% | ||
| Q1 25 | 2.3% | 45.4% | ||
| Q4 24 | 2.6% | 14.7% | ||
| Q3 24 | 7.9% | 5.3% | ||
| Q2 24 | 4.7% | 34.8% | ||
| Q1 24 | 8.2% | 34.2% |
| Q4 25 | $0.03 | $0.15 | ||
| Q3 25 | $-0.11 | $0.12 | ||
| Q2 25 | $0.01 | $0.02 | ||
| Q1 25 | $0.04 | $0.21 | ||
| Q4 24 | $0.06 | $0.05 | ||
| Q3 24 | $0.19 | $0.03 | ||
| Q2 24 | $0.10 | $0.20 | ||
| Q1 24 | $0.17 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $72.4M | $248.3M |
| Total Assets | $104.0M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $164.1M | ||
| Q3 25 | $7.3M | $127.4M | ||
| Q2 25 | $6.8M | $152.7M | ||
| Q1 25 | $5.1M | $132.1M | ||
| Q4 24 | $5.6M | $125.0M | ||
| Q3 24 | $5.0M | $137.4M | ||
| Q2 24 | $5.8M | — | ||
| Q1 24 | $4.8M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $72.4M | $248.3M | ||
| Q3 25 | $72.1M | $248.0M | ||
| Q2 25 | $72.4M | $244.6M | ||
| Q1 25 | $69.7M | $226.4M | ||
| Q4 24 | $70.2M | $195.1M | ||
| Q3 24 | $71.2M | $205.0M | ||
| Q2 24 | $68.9M | $8.8M | ||
| Q1 24 | $68.4M | $9.0M |
| Q4 25 | $104.0M | $380.4M | ||
| Q3 25 | $102.7M | $321.4M | ||
| Q2 25 | $99.3M | $315.3M | ||
| Q1 25 | $93.7M | $284.6M | ||
| Q4 24 | $94.0M | $266.1M | ||
| Q3 24 | $94.7M | $296.5M | ||
| Q2 24 | $89.3M | $19.5M | ||
| Q1 24 | $87.3M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $341.9K | $52.0M |
| Free Cash FlowOCF − Capex | $-479.7K | $51.2M |
| FCF MarginFCF / Revenue | -2.1% | 129.3% |
| Capex IntensityCapex / Revenue | 3.5% | 2.0% |
| Cash ConversionOCF / Net Profit | 1.44× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-1.8M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $341.9K | $52.0M | ||
| Q3 25 | $-1.4M | $-20.9M | ||
| Q2 25 | $609.7K | $-8.3M | ||
| Q1 25 | $803.7K | $1.9M | ||
| Q4 24 | $2.4M | $-7.3M | ||
| Q3 24 | — | $5.0M | ||
| Q2 24 | $1.9M | $19.2M | ||
| Q1 24 | — | $3.7M |
| Q4 25 | $-479.7K | $51.2M | ||
| Q3 25 | $-1.4M | $-20.9M | ||
| Q2 25 | $-171.2K | $-8.6M | ||
| Q1 25 | $293.1K | $1.7M | ||
| Q4 24 | $1.2M | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | $869.4K | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | -2.1% | 129.3% | ||
| Q3 25 | -6.3% | -48.3% | ||
| Q2 25 | -0.8% | -19.9% | ||
| Q1 25 | 1.5% | 3.5% | ||
| Q4 24 | 5.5% | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | 4.2% | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | 3.5% | 2.0% | ||
| Q3 25 | 0.2% | 0.1% | ||
| Q2 25 | 3.6% | 0.7% | ||
| Q1 25 | 2.7% | 0.5% | ||
| Q4 24 | 5.7% | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | 5.2% | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | 1.44× | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | 5.01× | -3.39× | ||
| Q1 25 | 1.85× | 0.09× | ||
| Q4 24 | 4.27× | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | 1.99× | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTIC
| Inside The USA To Unaffiliated Customers | $7.5M | 32% |
| Natur Tec | $6.0M | 26% |
| Acobal | $3.6M | 15% |
| Other | $2.7M | 12% |
| BR | $2.1M | 9% |
| Zerust OY | $1.4M | 6% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
